# A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days

> **NCT01234142** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 45 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** varenicline free base patch
- **DRUG:** varenicline free base patch
- **DRUG:** placebo patch
- **DRUG:** varenicline free base patch
- **DRUG:** placebo patch
- **DRUG:** varenicline free base patch
- **DRUG:** placebo patch

## Key facts

- **NCT ID:** NCT01234142
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2011-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01234142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01234142, "A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01234142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*